POOLBEG PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.05 GBX | -2.97% |
|
-0.38% | +44.20% |
| May. 01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
| May. 01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
Evolution of the average Target Price on Poolbeg Pharma PLC
Price target over the last 5 years
History of analyst recommendation changes
37e7bb6bb52f492aa778fe452.-MenAOhTB0NddON5X14k8inymfGG7MaLKXBTUmXAJNk.vKnWQtoCXRxoFa8yKGxQnxqg4a732rPCHzJiOD-fdqm8pvRmxSZtKjwmgA~162d2949fec504dffc449781fcb10c69
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1305
GBP
Average target price
0.21
GBP
Spread / Average Target
+60.92%
High Price Target
0.23
GBP
Spread / Highest target
+76.25%
Low Price Target
0.19
GBP
Spread / Lowest Target
+45.59%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- POLB Stock
- Consensus Poolbeg Pharma PLC
